The Pharmacokinetics and Electroencephalogram Response of Remifentanil Alone and in Combination with Esmolol in the Rat

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 1998 Feb 7

PMID 9453074

Citations 4

Authors

S H Haidar

J E Moreton

Z Liang

J F Hoke

K T Muir

N D Eddington

Affiliations

Soon will be listed here.

Abstract

Purpose: The goal of this study was to determine if the co-administration of esmolol (ES), a short acting cardioselective beta-blocker, significantly alters the pharmacokinetics and/or pharmacodynamics of remifentanil (REMI), an ultra short-acting opioid, in the rat.

Methods: Sprague-Dawley rats (N = 8, Wt. = 325 +/- 15 g) were surgically implanted with stainless steel cerebrocortical EEG electrodes three days before the study. Each rat was dosed with REMI (15 micrograms/kg/min), and REMI & ES (15 micrograms/kg/min and 600 micrograms/kg/min) for 21 minutes in a random crossover design. Six serial blood samples were collected over 25 minutes into test-tubes containing 0.5 ml acetonitrile. Blood samples were extracted with methylene chloride and analyzed by a validated GC-MS assay. EEG was captured and subjected to power spectral analysis (0.1-50 Hz) for spectral edge (97%).

Results: No significant differences (p < 0.05) were found in clearance (REMI = 287 + 73 ml/min/leg vs. REMI & ES = 289 +/- 148 ml/min kg) or Vd (REMI = 286 +/- 49 ml/kg vs REMI & ES = 248 + 40 ml/kg). A linked sigmoid Emax PK-PD model was used and the pharmacodynamic parameters were not statistically different. Mean Emax and EC50 after REMI were 18.0 +/- 6.0 Hz and 32 +/- 12 ng/ml; and after REMI + ES were 19 + 4.8 Hz and 26 + 8.6 ng/ml.

Conclusions: At the doses tested, there is no pharmacokinetic or pharmacodynamic interaction between remifentanil and esmolol in the rat.

Citing Articles

Analysis of species-dependent hydrolysis and protein binding of esmolol enantiomers.

Tang Y, Wang J, Hu H, Yao T, Zeng S J Pharm Anal. 2018; 2(3):220-225.

PMID: 29403746 PMC: 5760893. DOI: 10.1016/j.jpha.2012.01.007.

Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function.

Cotten J, Ge R, Banacos N, Pejo E, Husain S, Williams J Anesthesiology. 2011; 115(4):764-73.

PMID: 21572317 PMC: 3534755. DOI: 10.1097/ALN.0b013e31821950de.

Possible indications of beta-blockers in the perioperative period other than prevention of cardiac ischemia.

Kadoi Y, Saito S J Anesth. 2010; 24(1):81-95.

PMID: 20175288 DOI: 10.1007/s00540-009-0865-x.

Variability of drug self-administration in rats.

Panlilio L, Katz J, Pickens R, Schindler C Psychopharmacology (Berl). 2003; 167(1):9-19.

PMID: 12644888 DOI: 10.1007/s00213-002-1366-x.

References

Dershwitz M, Hoke J, Rosow C, Michalowski P, Connors P, Muir K . Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology. 1996; 84(4):812-20. DOI: 10.1097/00000542-199604000-00008. View

Holford N, Sheiner L . Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet. 1981; 6(6):429-53. DOI: 10.2165/00003088-198106060-00002. View

Sheiner L, Beal S . Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. J Pharm Sci. 1982; 71(12):1344-8. DOI: 10.1002/jps.2600711209. View

Glass P, Hardman D, Kamiyama Y, Quill T, Marton G, Donn K . Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg. 1993; 77(5):1031-40. DOI: 10.1213/00000539-199311000-00028. View

Amin H, Sopchak A, Esposito B, Henson L, Batenhorst R, Fox A . Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil. J Pharmacol Exp Ther. 1995; 274(1):34-9. View

Schumacher G, Barr J . Bayesian approaches in pharmacokinetic decision making. Clin Pharm. 1984; 3(5):525-30. View

Grosse C, Davis I, Arrendale R, Jersey J, Amin J . Determination of remifentanil in human blood by liquid-liquid extraction and capillary GC-HRMS-SIM using a deuterated internal standard. J Pharm Biomed Anal. 1994; 12(2):195-203. DOI: 10.1016/0731-7085(94)90030-2. View

Quon C, Mai K, Patil G, Stampfli H . Species differences in the stereoselective hydrolysis of esmolol by blood esterases. Drug Metab Dispos. 1988; 16(3):425-8. View

Scott J, Ponganis K, Stanski D . EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil. Anesthesiology. 1985; 62(3):234-41. DOI: 10.1097/00000542-198503000-00005. View

10.

Egan T, Minto C, Hermann D, Barr J, Muir K, Shafer S . Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology. 1996; 84(4):821-33. DOI: 10.1097/00000542-199604000-00009. View

11.

Pandit S, Green C . General anesthetic techniques. Int Anesthesiol Clin. 1994; 32(3):55-79. DOI: 10.1097/00004311-199432030-00006. View

12.

Sheiner L, Beal S, Rosenberg B, Marathe V . Forecasting individual pharmacokinetics. Clin Pharmacol Ther. 1979; 26(3):294-305. DOI: 10.1002/cpt1979263294. View

13.

Quon C, Gorczynski R . Pharmacodynamics and onset of action of esmolol in anesthetized dogs. J Pharmacol Exp Ther. 1986; 237(3):912-8. View

14.

Lozito R, La Marca S, Dunn R, Jerussi T . Single versus multiple infusions of fentanyl analogues in a rat EEG model. Life Sci. 1994; 55(17):1337-42. DOI: 10.1016/0024-3205(94)00766-7. View

15.

Reynolds R, Gorczynski R, Quon C . Pharmacology and pharmacokinetics of esmolol. J Clin Pharmacol. 1986; 26(S1):A3-A14. DOI: 10.1002/j.1552-4604.1986.tb02985.x. View

16.

Shafer S, Varvel J . Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology. 1991; 74(1):53-63. DOI: 10.1097/00000542-199101000-00010. View

17.

Gorczynski R, Shaffer J, Lee R . Pharmacology of ASL-8052, a novel beta-adrenergic receptor antagonist with an ultrashort duration of action. J Cardiovasc Pharmacol. 1983; 5(4):668-77. DOI: 10.1097/00005344-198307000-00023. View

18.

Hoffman W, Cunningham F, James M, Baughman V, Albrecht R . Effects of remifentanil, a new short-acting opioid, on cerebral blood flow, brain electrical activity, and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide. Anesthesiology. 1993; 79(1):107-13; discussion 26A. DOI: 10.1097/00000542-199307000-00016. View

19.

Quon C, Stampfli H . Biochemical properties of blood esmolol esterase. Drug Metab Dispos. 1985; 13(4):420-4. View

20.

Sebel P, Bovill J, Wauquier A, Rog P . Effects of high-dose fentanyl anesthesia on the electroencephalogram. Anesthesiology. 1981; 55(3):203-11. DOI: 10.1097/00000542-198109000-00004. View